About Alcea Biotech
Alcea Biotech is a Healthcare company. Pharmaceutical formulations and marketing operations in North India. Its Indian entity Alcea Biotech Private Limited reported revenue of ₹1.85 Cr. Alcea Biotech offers products and services including ROZALCEA-10/20 and INSURIZE XR-30/60. Its focus areas include Biotechnology, Formulation Development, Cardiac and Neuro Products and Pharmaceuticals.
Company details
Alcea Biotech is recognized as a young pharmaceutical company headquartered in Delhi, where marketing operations have been established in North India with a notable presence in major institutes. A robust portfolio has been created by the company, encompassing formulations for antibiotics, gastrointestinal treatments, cardiac care, general and neuro applications, psychiatric needs, and pain management. Products such as ROZALCEA and INSURIZE are offered, reflecting a commitment to healthcare solutions that are distributed through established channels.
- SectorsHealthcare
- Email••••••••
- Website alceabiotech.com
- Legal Name Alcea Biotech Pvt. Ltd
- Date of Incorporation 24 Jul, 2017
- Jurisdiction Delhi, India
- Indian entity revenue₹1.85 Cr
FY 2025 · +18% YoY
- Indian entity net profit₹2.9 Lakh
FY 2025 · 2% margin
- Indian entity EBITDA₹8.6 Lakh
FY 2025 · 5% margin
Associated legal entities of Alcea Biotech
Alcea Biotech operates through Alcea Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Alcea Biotech Private Limited CIN U51909DL2017PTC321107 | Active | 24 Jul 2017 | Delhi, Delhi | ₹1.8 Cr | 2 | View details |
Products & Services of Alcea Biotech
Alcea Biotech offers a comprehensive portfolio of products and services, including ROZALCEA-10/20 and INSURIZE XR-30/60.
Antibiotic formulations are provided for various treatments
Extended-release formulations are supplied for cardiac management
Board of directors of Alcea Biotech Private Limited (Alcea Biotech)
Alcea Biotech Private Limited is the primary company behind Alcea Biotech. The board of Alcea Biotech Private Limited currently have 2 directors; the longest-serving is Prashant Kumar Gupta, appointed in 2017. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prashant Kumar Gupta DIN 07863992 | Director | 24 Jul 2017 | 9 yrs 3 mo | Alcea Biotech Private Limited |
| Monika DIN 08676586 | Director | 22 Jan 2020 | 6 yrs 9 mo | Alcea Biotech Private Limited |
Financials of Alcea Biotech
Figures of Alcea Biotech Private Limited, the primary company behind Alcea Biotech, for FY 2025. Revenue was ₹1.85 Cr (+18% year on year). Net profit was ₹2.9 Lakh (2% margin). EBITDA was ₹8.6 Lakh (5% margin). Revenue has grown at a compounded annual rate of +17% over three years and +6% over five years.
- ₹1.85 CrRevenue · FY 2025 · +18% YoY
- ₹2.9 LakhNet profit · 2% margin
- ₹8.6 LakhEBITDA · 5% margin
- ₹1 LakhPaid-up capital
- +17%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Alcea Biotech Private Limited are on its company page.
Detailed financial statements for Alcea Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alcea Biotech
The primary company behind Alcea Biotech, Alcea Biotech Private Limited, reported revenue of ₹1.85 Cr for FY 2025, up 18% year on year.
Alcea Biotech is recognized as a young pharmaceutical company headquartered in Delhi, where marketing operations have been established in North India with a notable presence in major institutes. A robust portfolio has been created by the company, encompassing formulations for antibiotics, gastrointestinal treatments, cardiac care, general and neuro applications, psychiatric needs, and pain management. Products such as ROZALCEA and INSURIZE are offered, reflecting a commitment to healthcare solutions that are distributed through established channels.
Alcea Biotech offers ROZALCEA-10/20 and INSURIZE XR-30/60.
Alcea Biotech operates through Alcea Biotech Private Limited.
The legal entities of Alcea Biotech currently have 2 directors, including Monika, Prashant Kumar Gupta.